Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.

Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.

 Eur. J. Med. Chem., 2012, 58, 543-556. 

Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.

Eur. J. Med. Chem., 2012, 58, 171-183.

Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.

J. Med. Chem., 2012, 57, 225-233.

Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3K inhibitors. Eur.

Bioorg. Med. Chem. 2008, 16(9), 4932-4953.

Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.

Eur. J. Med. Chem., 2008, 43(7), 1469-1477.

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1) / glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies.

Bioorg. Med. Chem. Lett. 2006, 16, 3419-3423.

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.